LCFA presents lung cancer research grant opportunities to researchers worldwide who present the “best in science” projects in the field. These annual lung cancer research grant awards are 6-figure grants, allowing the researcher to set up a lab, hire personnel and begin to amass data to prove their hypotheses. LCFA awards research grants to young investigators who present projects that will have the best impact on the lives of lung cancer patients.
Dr. Zoltan Lohinai, of the National Koranyi Institute of Pulmonology, in Budapest, Hungary, was the recipient of a 2018 LCFA/IASLC/BMS lung cancer research grant. Read more about his research into the role of gut bacteria in lung cancer.
2020 Lung Cancer Foundation of America- Bristol-Myers Squibb/IASLCF Young Investigator Research Awards Objectives
The objective of these Awards is to support research in translational immuno-oncology undertaken by investigators who aim to improve the care and treatment of individuals with lung cancers. Examples include, but are not limited to, studies that are:
- designed to determine predictive features guiding the selection of patients for different immuno-oncology therapies;
- focused on the application of immuno-oncology therapies in combination with standard therapies, such as standard curative-intent strategies in early-stage disease;
- looking at ways to improve the effectiveness of immuno-oncology or even cure patients with metastatic lung cancer; and
- designed to facilitate care by minimizing treatment side effects.
Past Lung Cancer Research Grant Awardees
To attract the best and the brightest to the field of lung cancer, LCFA is committed to supporting young investigators with significant grant funding to pursue a long-term project over the course of multiple years. Meet some of our past Award Recipients.